-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I029veC4ZW5/6ysThxmyhKduxIH8Ks7usUwYS3/SR/qkwchmpKE9Ub8DKyg+05Ax CIYYzGLQzk0Hn42IgCXvjA== 0001181431-07-020329.txt : 20070320 0001181431-07-020329.hdr.sgml : 20070320 20070320180602 ACCESSION NUMBER: 0001181431-07-020329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070316 FILED AS OF DATE: 20070320 DATE AS OF CHANGE: 20070320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seely Lynn CENTRAL INDEX KEY: 0001327111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 07707462 BUSINESS ADDRESS: BUSINESS PHONE: (415) 543-3470 MAIL ADDRESS: STREET 1: 501 2ND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 SECOND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 501 SECOND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 4 1 rrd151618.xml X0202 4 2007-03-16 0 0001011835 MEDIVATION, INC. MDVN 0001327111 Seely Lynn C/O MEDIVATION, INC. 55 HAWTHORNE STREET, SUITE 610 SAN FRANCISCO CA 94105 0 1 0 0 Chief Medical Officer Common Stock 2007-03-16 4 M 0 9000 3.60 A 9000 D Common Stock 2007-03-16 4 S 0 9000 17.80 D 0 D Employee Stock Option (right to buy) 3.60 2007-03-16 4 M 0 9000 0 D 2005-03-14 2015-03-14 Common Stock 9000 351000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2006. Represents average price of sales ranging in price from $17.58 to $18.40. This option is immediately exercisable, in whole or in part, and the shares subject to the option vest according to the following schedule: 25% of the shares subject to the option vested on March 14, 2006, and 1/48th of the shares subject to the option vested and continue to vest on the first day of each full month thereafter so that all of the shares subject to the option shall be fully vested on March 1, 2009. /s/ C. Patrick Machado, Attorney-In-Fact for Lynn Seely, M.D. 2007-03-20 -----END PRIVACY-ENHANCED MESSAGE-----